Mauro Pistello Selected Research

Feline Acquired Immunodeficiency Syndrome (FAIDS)

6/2008	Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1.
10/2007	Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Pistello Research Topics

Disease

24	Infections 03/2022 - 04/2002
10	Viremia 01/2022 - 10/2008
9	COVID-19 01/2022 - 01/2020
7	Neoplasms (Cancer) 01/2022 - 03/2008
5	Melanoma (Melanoma, Malignant) 10/2021 - 01/2017
5	Acquired Immunodeficiency Syndrome (AIDS) 03/2009 - 07/2002
3	Disease Progression 12/2021 - 09/2006
3	Pneumonia (Pneumonitis) 11/2021 - 12/2020
2	Lymphoma (Lymphomas) 06/2022 - 01/2010
2	Coinfection 03/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 07/2007
2	Liver Diseases (Liver Disease) 10/2019 - 10/2008
2	Asthma (Bronchial Asthma) 10/2018 - 10/2005
2	HIV Infections (HIV Infection) 04/2016 - 05/2015
2	Vesicular Stomatitis 03/2009 - 09/2007
2	Feline Acquired Immunodeficiency Syndrome (FAIDS) 06/2008 - 10/2007
1	Zika Virus Infection 12/2022
1	Microcephaly 12/2022
1	Congenital Abnormalities (Deformity) 12/2022
1	Chronic Hepatitis B 03/2022
1	Reinfection 01/2022
1	Inflammation (Inflammations) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Superinfection 12/2021
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Adenocarcinoma 04/2021
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Cytokine Release Syndrome 01/2021
1	Chickenpox 04/2018
1	Herpes Zoster 04/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Persistent Infection 01/2017
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2016
1	Animal Disease Models 02/2016

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 04/2002
7	VaccinesIBA 01/2022 - 07/2002
6	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2002
5	Antiviral Agents (Antivirals)IBA 03/2022 - 04/2008
4	Acid CeramidaseIBA 10/2021 - 01/2017
4	CeramidesIBA 03/2021 - 01/2017
3	AntigensIBA 06/2022 - 02/2005
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2010
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 06/2012
2	LipidsIBA 01/2022 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2021
2	Neutralizing AntibodiesIBA 09/2021 - 06/2021
2	SphingolipidsIBA 03/2021 - 07/2019
2	Monoclonal AntibodiesIBA 01/2021 - 01/2010
2	Pharmaceutical PreparationsIBA 01/2021 - 06/2008
2	Viral ProteinsIBA 01/2020 - 01/2018
2	Alanine Transaminase (SGPT)IBA 10/2019 - 10/2015
2	Eosinophil Cationic ProteinIBA 10/2005 - 09/2004
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2022
1	nasIBA 03/2022
1	SofosbuvirIBA 03/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2022
1	Hepatitis B e AntigensIBA 03/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	SuperantigensIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	baricitinibIBA 12/2021
1	casirivimab and imdevimab drug combinationIBA 12/2021
1	bamlanivimab and etesevimab drug combinationIBA 12/2021
1	tocilizumab (atlizumab)FDA Link 12/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2021
1	Immunomodulating AgentsIBA 12/2021
1	C-Reactive ProteinIBA 12/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2021
1	Oxygen (Dioxygen)IBA 11/2021
1	Blood Group Antigens (Blood Groups)IBA 09/2021
1	Angiotensin-Converting Enzyme 2IBA 04/2021
1	Nicotine FDA Link 04/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2021
1	SphingosineIBA 03/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2021
1	protopineIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Janus Kinase 1IBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020
1	Single-Stranded DNA (DNA, Single Stranded)IBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Protein Sorting Signals (Signal Peptide)IBA 01/2018
1	NucleotidesIBA 01/2018
1	CytokinesIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	ChemokinesIBA 01/2017
1	Anti-Infective Agents (Microbicides)IBA 04/2016
1	Local Anti-Infective Agents (Antiseptics)IBA 04/2016

Therapy/Procedure

14	Therapeutics 01/2022 - 10/2005
5	Immunotherapy 04/2018 - 06/2005
4	Transplantation 10/2018 - 10/2008
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2010
2	Length of Stay 12/2021 - 12/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2016 - 05/2015
2	Liver Transplantation 08/2014 - 10/2008
1	Fecal Microbiota Transplantation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 12/2021
1	Operative Surgical Procedures 01/2020
1	Organ Transplantation 01/2016